Bessemer Group
ARIA

Bessemer Group’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Bessemer Group’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-530
Closed -$3K – 1777
2015
Q4 		$3K Buy
530
+490
+1,225% +$3.22K ﹤0.01% 1483
2015
Q3 		$0 Buy
+40
New +$308 ﹤0.01% 1817
2013
Q4 		– Sell
-269
Closed -$5K – 1416
2013
Q3 		$5K Sell
269
-172
-39% -$3.34K ﹤0.01% 1128
2013
Q2 		$8K Buy
+441
New +$7.82K ﹤0.01% 1077

Other funds holding ARIA

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Bessemer Group's ARIA Position: Q1 2016 in Review

Bessemer Group sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2016, closing a stake of 530 shares — an estimated $3K sold.

Bessemer Group first reported a position in ARIA in Q2 2013 and held it in 4 quarters. The position peaked at $8K in Q2 2013. 162 funds tracked by Wall St. Rank hold ARIA as of Q1 2016.

  • Bessemer Group reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2016 after selling out during the quarter.
  • Bessemer Group sold 530 Ariad Pharmaceuticals Inc shares in Q1 2016, an estimated $3K.
  • Bessemer Group first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 4 quarters.
  • Bessemer Group's Ariad Pharmaceuticals Inc position peaked at $8K in Q2 2013.
  • 162 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2016.

Based on Bessemer Group's 13F filing for Q1 2016, filed 11 May 2016.